FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

ALPHA ADVISORS, LLC

2. Date of Event Requiring Statement (MM/DD/YYYY)
2/6/2015 

3. Issuer Name and Ticker or Trading Symbol

CYTODYN INC [CYDY]

(Last)        (First)        (Middle)

P.O. BOX 2477

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            ___ X ___ 10% Owner
_____ Officer (give title below)          ___ X ___ Other (specify below)
/ indirect

(Street)

LAKELAND, FL 33806-2477       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
common stock   1864931   I   By Alpha Venture Capital Partners, L.P.  
common stock   230769   I   By Alpha Venture Capital Fund, L.P.  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
warrants to purchase common stock   10/23/2013   10/23/2018   common stock   932465   $0.75   I   By Alpha Venture Capital Partners, L.P.  
warrants to purchase common stock   10/23/2013   10/23/2018   common stock   115385   $0.75   I   By Alpha Venture Capital Fund, L.P.  
convertible promissory note   9/26/2014   9/26/2016   common stock   $2000000   $1   I   By Alpha Venture Capital Partners, L.P.  
warrants to purchase common stock   9/26/2014   12/31/2019   common stock   250000   $0.5   I   By Alpha Venture Capital Fund, L.P.  

Explanation of Responses:

Remarks:
The securities reported on this Form 3 are owned directly by Alpha Venture Capital Partners, L.P.-AVC Partners-or Alpha Venture Capital Fund, L.P.-AVC Fund-as indicated in Tables I and II of this Form 3. Alpha Venture Capital Management, LLC-AVC Management-is the general partner of AVC Partners and AVC Fund but does not make investment decisions on behalf of AVC Partners or AVC Funds. As the investment advisor of AVC Partners and AVC Fund, Alpha Advisors, LLC-Alpha Advisors-has the exclusive authority to make all investment decisions on behalf of AVCP and AVC Fund. Alpha Advisors does not directly receive dividends or proceeds of sale from the securities owned by AVC Partners or AVC Fund

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
ALPHA ADVISORS, LLC
P.O. BOX 2477
LAKELAND, FL 33806-2477

X
indirect
Alpha Venture Capital Partners, L.P.
P.O. BOX 2477
LAKELAND, FL 33806

X


Signatures
/s/Carl Dockery as Manager of Alpha Advisors, LLC 7/17/2015
** Signature of Reporting Person Date

/s/Carl Dockery as Manager of Alpha Venture Capital Management, LLC, General Partner of Alpha Venture Capital Partners, L.P. 7/17/2015
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
CytoDyn (QB) (USOTC:CYDY)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more CytoDyn (QB) Charts.
CytoDyn (QB) (USOTC:CYDY)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more CytoDyn (QB) Charts.